miR-345-3p Modulates M1/M2 Macrophage Polarization to Inhibit Inflammation in Bone Infection via Targeting MAP3K1 and

Yan Dai1, Xiaolan Yi1, Yahui Huang1

  • 1Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Insights

MicroRNA-345-3p (miR-345-3p) combats infection after fracture fixation by shifting M1 macrophages to M2. This process inhibits MAP3K1 and NF-κB pathways, offering new therapeutic targets for this bone infection.

Area of Science:

  • Biomedical Science
  • Immunology
  • Molecular Biology

Background:

  • Infection after fracture fixation (IAFF) is a severe complication causing bone destruction.
  • MicroRNA-345-3p (miR-345-3p) is a known biomarker for tibial infected nonunion, but its precise role in IAFF pathogenesis is unclear.

Purpose of the Study:

  • To elucidate the mechanistic role of miR-345-3p in the pathogenesis of IAFF.
  • To investigate how miR-345-3p influences macrophage polarization and related signaling pathways in IAFF.

Main Methods:

  • Utilized in vivo rat models of IAFF and in vitro experiments with bone marrow-derived macrophages.
  • Assessed macrophage polarization markers (M1/M2), cytokine expression, and signaling pathway activation (MAP3K1, NF-κB).
  • Investigated the effect of miR-345-3p mimics and MAP3K1 manipulation on macrophage phenotype and inflammatory responses.

Main Results:

  • IAFF in rats showed decreased miR-345-3p expression, increased M1 macrophages, and elevated pro-inflammatory factors.
  • miR-345-3p promoted M1 to M2 macrophage polarization, reducing M1 markers (CD86, TNF-α) and increasing M2 markers (CD163, IL-10).
  • miR-345-3p inhibited the MAP3K1/NF-κB signaling pathway, which was crucial for M1 macrophage polarization.

Conclusions:

  • miR-345-3p plays a protective role in IAFF by promoting M2 macrophage polarization via the MAP3K1 and NF-κB pathways.
  • These findings highlight miR-345-3p as a potential therapeutic target for managing IAFF.
  • Understanding this mechanism offers insights into novel immunotherapeutic strategies for bone infections.